Expert Discusses Necessity Of Laboratory Testing For Adults On Long-Term Dupilumab Therapy For Moderate To Severe Atopic Dermatitis

According to Healio (4/25, Mullin), in a “video from AAD VMX 2021, Andrew Blauvelt, MD, MBA, discusses his presentation on the necessity of laboratory testing for adult patients on long-term dupilumab treatment for moderate to severe atopic dermatitis.”